CLB Valuation

Core Laboratories Inc

Add to Watchlist

Advanced Chart

12.020

-1.420(-10.570%)

Overview
Forecast
Valuation

CLB Relative Valuation

CLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLB is overvalued; if below, it's undervalued.

Historical Valuation

Core Laboratories Inc(CLB) is now in theUndervaluedzone, suggesting that its currentforward PEratio of14.31is consideredUndervaluedcompared with the five-year average of28.62.The fair price of Core Laboratories Inc(CLB)is between14.09to27.96according to relative valuation methord.Compared to the current price of12.02USD, Core Laboratories Inc isUndervalued By 14.71%.

Relative Value

Fair Zone

14.09-27.96

Current Price：12.02

14.71%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.23

P/B

Median3y

4.60

Median5y

7.71

6.89

FCF Yield

Median3y

2.20

Median5y

3.05

Competitors Valuation Multiple

The average P/S ratio for CLB's competitors is 1.51, providing a benchmark for relative valuation. Core Laboratories Inc Corp (CLB) exhibits a P/S ratio of 1.19, which is -21.00% above the industry average. Given its robust revenue growth of 0.80%, this premium appearsunsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

CLB.N

Core Laboratories Inc